Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with RibavirinJordan J. Feld, Barry Bernstein, Ola Weiland et al.|New England Journal of Medicine|2014Cited by 907
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with CirrhosisFred Poordad, Barry Bernstein, Christophe Hézode et al.|New England Journal of Medicine|2014Cited by 877
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trialsGregory J. Dore, Thomas Podsadecki, Brian Conway et al.|Journal of Hepatology|2015Cited by 68